Women’s Advocacy Groups Strive For FDA Transparency On Silicone Implants
This article was originally published in The Gray Sheet
A Freedom of Information Act request filed June 9 represents the National Organization for Women's latest effort to increase transparency in FDA's review of two silicone breast implant PMA applications
You may also be interested in...
The Senate Health committee has scheduled a June 15 vote on the nomination of FDA Commissioner-designee Lester Crawford, following an HHS Inspector General investigation clearing him of allegations of misconduct
The Senate HELP Committee is reviewing a letter from six women's groups requesting a congressional oversight investigation into the recent FDA panel meeting on silicone breast implants
FDA's General & Plastic Surgery Devices Panel concurred with public commenters who urged that women should have access to silicone breast implants by recommending approval for Mentor's premarket approval application April 13